Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Medical Microbiology Masters Student

FY 2016-17

Summary
Understanding LAG-3-associated defects in iNKT cell function in HIV infection. Background: Human immunodeficiency virus (HIV) is currently a worldwide issue, with 36.7 million current HIV-infected individuals and 2.1 million new infections in 2015. The hallmark of chronic HIV infection is immune exhaustion, characterized by a definitive loss of immune system effectiveness. Immune exhaustion is seen regardless of the use of anti-retroviral therapies (ART), which are the one of the most effective HIV therapeutics to date. Lymphocyte-activation gene (LAG-3), an inhibitory exhaustion marker expressed on immune cells, is associated with immune dysfunction observed in HIV patients. Our lab has shown that increased LAG-3 expression on invariant Natural Killer T (iNKT) cells correlates with decrease cell functionality in HIV infection. iNKT cells are critical contributors to a healthy immune response to viral infection, therefore dysfunctional iNKT cells render HIV-infected individuals susceptible to an abundance of pathogens. Hypothesis: In HIV infection, we hypothesize that blocking LAG-3 via an antibody blockade will restore function of iNKT cells.Approach: Our lab has experience designing blockade systems, including a LAG-3 blockade. We will execute short-term and long-term iNKT cell stimulations of HIV-infected samples with or without the presence of our LAG-3 blockade system. Through our established flow cytometry protocols, we will assess the iNKT cell population and expression of both LAG-3 and cytokines, important signalling molecules that represent the functional ability of the iNKT cells. The long-term goal is to restore immune cell function thereby controlling HIV replication and decreasing the dependency on ART.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367032
Name
Balasko Allison
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Medical Microbiology Masters Student
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibody Therapeutic; Cytokines; Exhaustion Marker Lag-3; Hiv; Immune Exhaustion; Immunology; Inkt Cells; Innate Immune System; Microbiology; Virology
Abstract
Understanding LAG-3-associated defects in iNKT cell function in HIV infection. Background: Human immunodeficiency virus (HIV) is currently a worldwide issue, with 36.7 million current HIV-infected individuals and 2.1 million new infections in 2015. The hallmark of chronic HIV infection is immune exhaustion, characterized by a definitive loss of immune system effectiveness. Immune exhaustion is seen regardless of the use of anti-retroviral therapies (ART), which are the one of the most effective HIV therapeutics to date. Lymphocyte-activation gene (LAG-3), an inhibitory exhaustion marker expressed on immune cells, is associated with immune dysfunction observed in HIV patients. Our lab has shown that increased LAG-3 expression on invariant Natural Killer T (iNKT) cells correlates with decrease cell functionality in HIV infection. iNKT cells are critical contributors to a healthy immune response to viral infection, therefore dysfunctional iNKT cells render HIV-infected individuals susceptible to an abundance of pathogens. Hypothesis: In HIV infection, we hypothesize that blocking LAG-3 via an antibody blockade will restore function of iNKT cells.Approach: Our lab has experience designing blockade systems, including a LAG-3 blockade. We will execute short-term and long-term iNKT cell stimulations of HIV-infected samples with or without the presence of our LAG-3 blockade system. Through our established flow cytometry protocols, we will assess the iNKT cell population and expression of both LAG-3 and cytokines, important signalling molecules that represent the functional ability of the iNKT cells. The long-term goal is to restore immune cell function thereby controlling HIV replication and decreasing the dependency on ART.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Balasko, Allison
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~